"Medidata is at the forefront of a critical shift in the life sciences sector," said Anthony Costello, CEO, Medidata. "By harnessing AI-powered solutions and partnering with visionaries, we aren't ...

Patient enrollment is expected to begin in the first half of 2025, subject to final protocol review by regulatory authorities ...

Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded. [Operator instructions] I would now like to turn the call over to Mr. Peter ...

CEO Haruo Naito highlighted a 9% year-on-year revenue increase to 601.2 billion yen, with a focus on the pharmaceutical business driving growth. Key contributors included LEQEMBI with a 28.1 billion ...

Eisai and Biogen have completed their rolling biologics license application in the US for a subcutaneous formulation of Alzheimer's disease therapy Leqembi previously delayed by the FDA on ...

Eisai and Biogen’s Alzheimer’s disease therapy Leqembi is due to be launched in Japan, its second market, on 20th December, and will be priced quite a lot lower there than in the US.

Elevate your brand this year with only the best website builders out there. We've done the research and testing, so you don't have to. Dianna Gunn built her first WordPress website in 2008.

We argue against selling Geron at current prices, citing strong market potential of imetelstat and Royalty Pharma deal ...

Editorial Note: Forbes Advisor may earn a commission on sales made from partner links on this page, but that doesn't affect our editors' opinions or evaluations. Thanks to website builders, it’s ...

The best website builders let you make pages with more design flexibility than anything you'll find on social media, though with fewer tools than traditional web hosting services. We've been ...